Pages that link to "Q109648592"
Jump to navigation
Jump to search
The following pages link to Nina Singh (Q109648592):
Displaying 50 items.
- Unique characteristics of cryptococcosis identified after death in patients with liver cirrhosis: comparison with concurrent cohort diagnosed antemortem. (Q30275986) (← links)
- Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes. (Q30300307) (← links)
- Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen (Q30426015) (← links)
- Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis (Q30426041) (← links)
- Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis (Q30433949) (← links)
- Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality (Q30438524) (← links)
- Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings (Q30438585) (← links)
- Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis (Q30441628) (← links)
- Immunotherapy with tacrolimus (FK506) does not select for resistance to calcineurin inhibitors in Candida albicans isolates from liver transplant patients (Q30446573) (← links)
- Pretransplant cryptococcosis and outcome after liver transplantation (Q30450569) (← links)
- Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression. (Q30459073) (← links)
- Aspergillus infections in transplant recipients (Q33719294) (← links)
- Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. (Q34020746) (← links)
- Burkholderia cepacia infection and lung transplantation (Q35032668) (← links)
- Bronchiolitis obliterans and lung transplantation: evidence for an infectious etiology (Q35032680) (← links)
- Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients (Q35552743) (← links)
- Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients (Q35743055) (← links)
- Severing the Gordian knot of prevention of cytomegalovirus in liver transplant recipients: the principle is the sword (Q36202528) (← links)
- Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used? (Q36521179) (← links)
- Immune reconstitution syndrome associated with opportunistic mycoses (Q36830371) (← links)
- Immune reconstitution syndrome and exacerbation of infections after pregnancy (Q36961736) (← links)
- Alternaria alternata soft tissue infection in a forearm transplant recipient (Q36999896) (← links)
- Combination therapeutic approaches for the management of invasive aspergillosis in organ transplant recipients (Q37078394) (← links)
- Cryptococcosis in solid organ transplant recipients: current state of the science (Q37226750) (← links)
- Protothecosis after liver transplantation (Q37231195) (← links)
- Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens (Q37255855) (← links)
- Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients (Q37385419) (← links)
- Cytomegalovirus infection in critically ill patients: a systematic review (Q37482179) (← links)
- Invasive mould infections: a multi-disciplinary update (Q37483661) (← links)
- Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients (Q37502649) (← links)
- Colitis as a manifestation of infliximab-associated disseminated cryptococcosis (Q37574613) (← links)
- In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients (Q37625139) (← links)
- The inflammasome regulatory pathway and infections: Role in pathophysiology and clinical implications (Q37800522) (← links)
- A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients (Q37855078) (← links)
- Mucormycosis: its contemporary face and management strategies. (Q37859952) (← links)
- Opportunistic infection-associated immune reconstitution syndrome in transplant recipients. (Q37892236) (← links)
- Mucormycosis in organ and stem cell transplant recipients (Q37995161) (← links)
- Inflammasome expression and cytomegalovirus viremia in critically ill patients with sepsis (Q38760428) (← links)
- Transmission of viral disease to the recipient through the donor liver (Q38973577) (← links)
- Adherence to protease inhibitor therapy and outcomes in patients with HIV infection (Q39605935) (← links)
- Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes (Q39652863) (← links)
- Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007. (Q40030147) (← links)
- The Times, They are a-Changing: HOPE for HIV-to-HIV Organ Transplantation (Q40295010) (← links)
- Improving the Diagnosis of Legionella Pneumonia within a Healthcare System through a Systematic Consultation and Testing Program (Q40652283) (← links)
- Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens (Q40771289) (← links)
- Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum (Q40882839) (← links)
- Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients (Q41179863) (← links)
- Viral infections in solid organ transplant recipients: novel updates and a review of the classics (Q41922937) (← links)
- Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients. (Q42255653) (← links)
- Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients (Q42972017) (← links)